45 CFR § 180 compliance
F · 55
This hospital published little of what § 180 requires.
●Machine-readable file published
○Gross / standard charges
○Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
16,378
Insurances with rates
6
CPT / HCPCS codes
12,741
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J2351 | ocrelizumab-hyaluronidase-ocsq 920-23000 mg-unit/23 mL Solution 23 mL Vial | $175,458 | $96,502 | — | — | 9 |
| J9228 | ipilimumab 200 MG/40ML Solution 40 mL Vial | $145,601 | $80,080 | — | — | 9 |
| J9269 | tagraxofusp-erzs 1000 MCG/ML Solution 1 mL Vial | $138,417 | $76,130 | — | — | 9 |
| J2507 | Pegloticase 8 MG/ML Solution 1 mL Vial | $127,605 | $70,183 | — | — | 9 |
| J0202 | alemtuzumab 12 MG/1.2ML Solution 1.2 mL Vial | $125,171 | $68,844 | — | — | 9 |
| J9281 | mitoMYcin 80 (2 x 40) MG Recon Soln 1 Each Box | $100,383 | $55,211 | — | — | 9 |
| 33249 | HC INSERT REPLC PERM IMPL DEFIB W TRANSVEN LEAD(S) DUAL CHAMBR | $99,497 | $54,723 | — | — | 8 |
| A9606 | Radium Ra 223 Dichloride 30 MCCI/ML Solution 1 Each Vial | $90,267 | $49,647 | — | — | 10 |
| J2350 | ocrelizumab 300 MG/10ML Solution 10 mL Vial | $87,734 | $48,254 | — | — | 9 |
| J3241 | teprotumumab-trbw 500 MG Recon Soln 1 Each Vial | $74,432 | $40,938 | — | — | 9 |
| J9334 | efgartigimod alfa-hyaluronidase-qvfc 1008-11200 mg-UT/5.6 mL Solution 5.6 mL Vial | $68,386 | $37,612 | — | — | 9 |
| 37227 | HC REVASC, ENDVASC, FEM, POPLIT ART, W STENT & ATHRECT | $64,414 | $35,428 | — | — | 8 |
| J9026 | tarlatamab-dlle 10 MG Recon Soln 1 Each Vial | $63,760 | $35,068 | — | — | 9 |
| J9298 | nivolumab-relatlimab-rmbw 240-80 mg/20mL Solution 20 mL Vial | $62,005 | $34,103 | — | — | 9 |
| J1628 | guselkumab 200 MG/20ML Solution 20 mL Vial | $61,917 | $34,055 | — | — | 9 |
| J9043 | cabazitaxel Solution 1.5 mL Vial | $58,886 | $32,387 | — | — | 9 |
| J9316 | pertuzumab/trastuzumab/hyaluronidase-zzxf 80-40-2000 MG-MG-U/ML Solution 15 mL Vial | $57,073 | $31,390 | — | — | 9 |
| 37231 | HC REVASC, ENDVASC, TIB, PERON ART, INIT VES, W STENT & ATHRECT | $54,808 | $30,144 | — | — | 8 |
| C9602 | HC PTC ATHRECT DRUG ELUT STNT ANGPLAST SGL BRNCH | $52,026 | $28,614 | — | — | 8 |
| J9042 | brentuximab 5 mg/mL Recon Soln 1 Each Vial | $50,035 | $27,519 | — | — | 17 |
| J2329 | ublituximab-xiiy 150 MG/6ML Solution 6 mL Vial | $47,228 | $25,975 | — | — | 9 |
| J9024 | atezolizumab-hyaluronidase-tqjs 1875-30,000 mg-unit/15 mL Solution 15 mL Vial | $46,147 | $25,381 | — | — | 9 |
| 36906 | HC PERC TRANSLUM MECH THROMBECT/INFUS, DIALYS CIRCUIT, PERIPH STENT/PTA | $45,327 | $24,930 | — | — | 8 |
| J9153 | DAUNOrubicin-cytarabine liposomal 44-100 MG Recon Susp 1 Each Vial | $44,162 | $24,289 | — | — | 9 |
| J2327 | risankizumab-rzaa 600 MG/10ML Solution 10 mL Vial | $44,094 | $24,252 | — | — | 9 |
| J9144 | daratumumab-hyaluronidase-fihj 1800-30000 mg-UT/15 mL Solution 15 mL Vial | $43,360 | $23,848 | — | — | 9 |
| 37229 | HC REVASC, ENDVASC, TIB, PERON ART, INIT VES, W ATHRECT | $42,588 | $23,423 | — | — | 8 |
| 37225 | HC REVASC, ENDVASC, FEM, POPLIT ART, W ATHRECT | $42,344 | $23,289 | — | — | 8 |
| J1930 | lanreotide acetate 120 MG/0.5ML Solution 0.5 mL Syringe | $40,649 | $22,357 | — | — | 9 |
| J3380 | vedolizumab 60 mg/mL Recon Soln 1 Each Vial | $39,790 | $21,884 | — | — | 9 |
| C9607 | HC PERC TRNSLM RVAS CHRONIC OCCL DRG ELUT STNT SGL | $39,097 | $21,503 | — | — | 8 |
| 37230 | HC REVASC, ENDVASC, TIB, PERON ART, INIT VES, W STENT | $38,928 | $21,410 | — | — | 8 |
| 37226 | HC REVASC, ENDVASC, FEM, POPLIT ART, W STENT | $38,353 | $21,094 | — | — | 8 |
| J3263 | toripalimab-tpzi 240 mg/6 mL Solution 6 mL Vial | $38,118 | $20,965 | — | — | 9 |
| 36905 | HC PERC TRANSLUM MECH THROMBECT/INFUS, DIALYS CIRCUIT, PERIPH PTA | $36,783 | $20,231 | — | — | 8 |
| J9301 | obinutuzumab 1000 MG/40ML Solution 40 mL Vial | $35,327 | $19,430 | — | — | 9 |
| J3101 | tenecteplase 50 mg/10 mL Kit 1 Each Box | $35,273 | $19,400 | — | — | 8 |
| 92933 | HC PTC ATHRECT W INTRCOR STNT ANGIOPLAST SGL BRNCH | $34,546 | $19,000 | — | — | 8 |
| 36903 | HC INTRO NEEDLE/CATH, DIALYSIS CIRCUIT, W/ PERIPHERAL STENT/PTA | $34,413 | $18,927 | — | — | 8 |
| J2267 | mirikizumab-mrkz 300 MG/15ML Solution 15 mL Vial | $33,586 | $18,472 | — | — | 9 |
| J9223 | lurbinectedin 4 mg/8 mL Recon Soln 1 Each Vial | $33,266 | $18,296 | — | — | 8 |
| C1772 | PUMP SYNCHROMED III 20MLC | $33,163 | $18,239 | — | — | 9 |
| C1721 | HC CARDIOVERTER-DEFIBRILLATOR, DUAL CHAMBER | $33,000 | $18,150 | — | — | 9 |
| C1722 | HC CARDIOVERTER-DEFIBRILLATOR, SINGLE CHAMBER | $33,000 | $18,150 | — | — | 9 |
| J9022 | Atezolizumab 840 MG/14ML Solution 14 mL Vial | $32,308 | $17,769 | — | — | 9 |
| C9604 | HC PERC TRNSLM RVSC BYP GRFT DRG ELUT STNT SGL VSL | $32,151 | $17,683 | — | — | 8 |
| C9600 | HC PERCUT TRNSCATH PLC DRUG ELUT STENT SGL BRNCH | $32,150 | $17,683 | — | — | 8 |
| J9299 | nivolumab 240 MG/24ML Solution 24 mL Vial | $31,943 | $17,569 | — | — | 9 |
| 37233 | HC REVASC, ENDVASC, TIB/PERON ART, EA ADL VES, W ATHRECT (AD) | $31,648 | $17,406 | — | — | 8 |
| 33228 | HC REM PERM PM PLSE GEN W REPL PLSE GEN DUAL LEAD | $30,563 | $16,810 | — | — | 7 |
Showing top 50 of 16,378 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.